InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
5,505.00
(
-0.71%
)
US TECH 100
19,000.00
(
-0.94%
)
Dow Jones
40,287.53
(
-0.93%
)
Brent Oil
81.88
(
0.00%
)
Bitcoin
66,558.09
(
-0.24%
)
Post# of 252642
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 831
Posts 120081
Boards Moderated 16
Alias Born 09/05/2002

DewDiligence

Member Level

Re: None

Tuesday, 10/30/2007 4:49:30 PM

Tuesday, October 30, 2007 4:49:30 PM

Post# of 252642
HIV screening—specifically the patchwork of US
state laws that inhibit it— is highly relevant to
investors in the antiviral sector. GILD has cited
increased screening as the main growth driver for
HIV drugs in the US—provided that states get out
of the business of unduly protecting patients from
knowing whether they are infected.

http://news.yahoo.com/s/nm/20071030/hl_nm/cdc_proposals_dc_1

>>
CDC Proposals for HIV Testing Clash with State Laws

By David Douglas

Routine testing for HIV recommended by the Centers for Disease Control and Prevention (CDC) appears to be inconsistent with laws in many states, according to findings published in the medical journal PLoS ONE.

CDC recommends routine HIV testing for all Americans between 13 and 64 years old. This would eliminate previous requirements for written consent and pretest counseling, Dr. Leslie E. Wolf, who is currently at Georgia State University College of Law, Atlanta, and colleagues note.

However, they point out that "this approach may conflict with state requirements." In fact, most states have laws that require specific consent. Fourteen require written informed consent and 19 require oral consent. Eleven states require pretest counseling.

Because of such legislation, "the majority of states would need to amend their laws to permit routine HIV testing." For example, states that require disclosures of specific information during pretest counseling or the informed consent process "would need either to eliminate those disclosures or make them recommendations, rather than requirements."

However, the team found that "despite strong public health recommendations" to facilitate testing, "the trend in states that have amended their laws since 2004 has been to reaffirm requirements for pretest counseling and consent."

Given the continued stigma surrounding HIV, the investigators add, it is likely that a reasonable patient standard for informed consent "would require more information about HIV testing than is currently contemplated under the CDC's recommendations."

Wolf told Reuters Health: "We think a balance can be struck so that we can increase testing among those who are unaware of their status without losing the opportunity to engage in education about HIV and prevention."

"But," she noted, "we need a better understanding of what's happening in the states when they consider changing testing laws."

SOURCE: PLoS ONE, October 2007.
<<

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up